AVCNF
Avicanna Inc.
OTC Markets OTCQXUSDEQUITY
DELAYED
Last price
0.10
▲ 0.00 (3.19%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.10
Prev close
0.09
Day high
0.10
Day low
0.10
Volume
100
Market cap
—
P/E (TTM)
—
52W range
0.07 – 0.24
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+1.04%
+2.4%
1M
+1.04%
-2.7%
3M
-3.00%
-6.1%
6M
-21.77%
-32.8%
YTD
-40.12%
-52.4%
1Y
-54.88%
-74.9%
3Y
-50.00%
-124.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $25.48M | $25.46M | $16.79M | $4.05M | — | +0.1% |
| Operating revenue | $25.48M | $25.46M | $16.79M | $4.05M | — | +0.1% |
| Cost of revenue | $11.96M | $13.26M | $10.13M | $2.93M | — | -9.8% |
| Gross profit | $13.52M | $12.19M | $6.66M | $1.12M | — | +10.9% |
| Research & development | $256.42K | $178.16K | $330.66K | $276.94K | — | +43.9% |
| Selling, general & admin | $15.12M | $16.32M | $13.50M | $9.99M | — | -7.4% |
| Total operating expense | $16.30M | $17.84M | $15.04M | $11.53M | — | -8.6% |
| Operating income | -$2.78M | -$5.64M | -$8.38M | -$10.41M | — | +50.7% |
| Net interest income | -$51.84K | -$333.65K | -$610.26K | -$1.67M | — | +84.5% |
| Pre-tax income | -$2.76M | -$4.58M | -$8.74M | -$14.74M | — | +39.8% |
| Tax provision | — | — | — | $0 | $13.77K | — |
| Net income | -$2.84M | -$3.99M | -$8.74M | -$14.74M | — | +28.8% |
| Net income to common | -$2.84M | -$3.99M | -$8.74M | -$14.74M | — | +28.8% |
| Basic EPS | -0.02 | -0.04 | -0.10 | -0.25 | — | +50.0% |
| Diluted EPS | -0.02 | -0.04 | -0.10 | -0.25 | — | +50.0% |
| EBIT | -$2.71M | -$4.25M | -$8.13M | -$13.06M | — | +36.2% |
| EBITDA | -$1.96M | -$3.39M | -$7.36M | -$12.18M | — | +42.1% |
| Basic shares | 114.72M | 100.03M | 84.71M | 59.17M | — | +14.7% |
| Diluted shares | 114.72M | 100.03M | 84.71M | 59.17M | — | +14.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $280.63K | $448.03K | $477.20K | $1.19M | — | -37.4% |
| Cash & short-term investments | $280.63K | $448.03K | $477.20K | $1.19M | — | -37.4% |
| Accounts receivable | $2.70M | $2.95M | $2.94M | $2.12M | — | -8.6% |
| Inventory | $3.85M | $3.27M | $4.54M | $3.24M | — | +17.6% |
| Total current assets | $7.90M | $6.94M | $8.46M | $7.06M | — | +13.8% |
| Property, plant & equipment | $12.39M | $11.27M | $11.99M | $10.39M | — | +9.9% |
| Goodwill & intangibles | $960.43K | $1.20M | $1.52M | $167.63K | — | -20.2% |
| Total assets | $21.24M | $19.41M | $21.97M | $17.62M | — | +9.4% |
| Total current liabilities | $9.18M | $8.60M | $12.38M | $11.41M | — | +6.7% |
| Current debt | — | — | $1.56M | $2.66M | $1.09M | — |
| Long-term debt | — | — | — | $179.55K | $415.83K | — |
| Total debt | $0 | $109.23K | $1.80M | $3.21M | — | -100.0% |
| Total liabilities | $9.86M | $9.71M | $14.00M | $14.16M | — | +1.5% |
| Retained earnings | -$105.24M | -$102.39M | -$98.71M | -$90.83M | — | -2.8% |
| Shareholder equity | $2.84M | $2.62M | -$112.50K | -$383.56K | — | +8.5% |
| Working capital | -$1.28M | -$1.67M | -$3.92M | -$4.34M | — | +23.0% |
| Net tangible assets | $1.88M | $1.42M | -$1.63M | -$551.19K | — | +32.9% |
| Shares issued | 118.04M | 110.22M | 90.68M | 74.95M | — | +7.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$2.76M | -$4.58M | -$8.74M | -$14.74M | +39.8% |
| Depreciation & amortisation | $743.05K | $853.74K | $777.29K | $887.33K | -13.0% |
| Stock-based compensation | $1.17M | $2.18M | $1.94M | $1.04M | -46.3% |
| Change in working capital | -$56.38K | -$437.75K | $4.36M | $1.43M | +87.1% |
| Operating cash flow | -$1.18M | -$2.55M | -$1.40M | -$7.44M | +53.6% |
| Capital expenditure | -$255.87K | -$402.57K | -$557.56K | -$66.78K | +36.4% |
| Investing cash flow | -$255.84K | -$402.57K | -$3.05M | $810.24K | +36.4% |
| Financing cash flow | $963.17K | $3.42M | $3.55M | $9.90M | -71.9% |
| Free cash flow | -$1.44M | -$2.95M | -$1.96M | -$7.50M | +51.3% |
| End cash position | $280.63K | $448.03K | $477.20K | $1.19M | -37.4% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.68M | $6.60M | $6.40M | $6.16M | $6.32M | +1.2% |
| Operating revenue | $6.68M | $6.60M | $6.40M | $6.16M | $6.32M | +1.2% |
| Cost of revenue | $2.84M | $2.96M | $3.25M | $3.03M | $2.72M | -4.0% |
| Gross profit | $3.84M | $3.64M | $3.15M | $3.13M | $3.60M | +5.5% |
| Research & development | $15.99K | $56.72K | $32.10K | $116.54K | $51.07K | -71.8% |
| Selling, general & admin | $3.97M | $4.05M | $4.28M | $3.52M | $3.27M | -2.1% |
| Total operating expense | $4.15M | $4.44M | $4.52M | $3.83M | $3.51M | -6.6% |
| Operating income | -$309.02K | -$803.78K | -$1.37M | -$699.97K | $94.19K | +61.6% |
| Net interest income | -$15.62K | -$11.33K | -$5.82K | -$3.06K | -$31.63K | -37.8% |
| Pre-tax income | -$288.89K | -$749.85K | -$1.38M | -$701.18K | $74.72K | +61.5% |
| Tax provision | $0 | — | — | — | $0 | — |
| Net income | -$288.89K | -$834.86K | -$1.38M | -$701.18K | $74.72K | +65.4% |
| Net income to common | -$288.89K | -$834.86K | -$1.38M | -$701.18K | $74.72K | +65.4% |
| Basic EPS | 0.00 | — | -0.01 | -0.01 | 0.00 | — |
| Diluted EPS | 0.00 | — | -0.01 | -0.01 | 0.00 | — |
| EBIT | -$273.28K | -$738.51K | -$1.38M | -$698.11K | $106.35K | +63.0% |
| EBITDA | -$107.98K | -$573.91K | -$1.18M | -$506.54K | $299.34K | +81.2% |
| Basic shares | 119.08M | — | 114.64M | 112.12M | 110.37M | — |
| Diluted shares | 119.08M | — | 114.64M | 112.12M | 110.37M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $372.10K | $280.63K | $464.85K | $207.64K | $456.76K | +32.6% |
| Cash & short-term investments | $372.10K | $280.63K | $464.85K | $207.64K | $456.76K | +32.6% |
| Accounts receivable | $2.57M | $2.70M | $2.48M | $2.82M | $2.39M | -4.7% |
| Inventory | $4.09M | $3.85M | $4.56M | $4.39M | $4.35M | +6.3% |
| Total current assets | $8.39M | $7.90M | $7.86M | $7.68M | $7.61M | +6.2% |
| Property, plant & equipment | $12.79M | $12.39M | $12.29M | $11.71M | $11.99M | +3.3% |
| Goodwill & intangibles | $899.81K | $960.43K | $1.02M | $1.08M | $1.14M | -6.3% |
| Total assets | $22.08M | $21.24M | $21.17M | $20.47M | $20.75M | +3.9% |
| Total current liabilities | $8.71M | $9.18M | $8.70M | $8.72M | $8.92M | -5.1% |
| Total debt | $0 | $0 | $0 | $37.09K | $73.50K | — |
| Total liabilities | $9.29M | $9.86M | $9.47M | $9.62M | $9.92M | -5.7% |
| Retained earnings | -$105.82M | -$105.24M | -$104.01M | -$102.76M | -$102.14M | -0.6% |
| Shareholder equity | $3.87M | $2.84M | $3.11M | $2.55M | $3.02M | +36.1% |
| Working capital | -$321.27K | -$1.28M | -$833.13K | -$1.04M | -$1.30M | +74.9% |
| Net tangible assets | $2.97M | $1.88M | $2.09M | $1.47M | $1.88M | +57.8% |
| Shares issued | 125.79M | 118.04M | 117.81M | 113.81M | 111.86M | +6.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$288.89K | -$749.85K | -$1.38M | -$701.18K | $74.72K | +61.5% |
| Depreciation & amortisation | $165.30K | $164.60K | $193.89K | $191.57K | $192.99K | +0.4% |
| Stock-based compensation | $68.74K | $355.61K | $433.37K | $174.77K | $207.31K | -80.7% |
| Change in working capital | -$807.01K | -$35.03K | $61.53K | $307.69K | -$390.56K | -2,203.6% |
| Operating cash flow | -$956.36K | -$191.05K | -$842.52K | -$129.98K | -$17.68K | -400.6% |
| Capital expenditure | -$12.99K | -$7.88K | -$22.67K | -$85.30K | -$140.03K | -64.9% |
| Investing cash flow | -$12.99K | -$8.92K | -$22.63K | -$84.27K | -$140.03K | -45.6% |
| Share buybacks | — | — | — | — | $0 | — |
| Financing cash flow | $1.48M | -$69.52K | $1.01M | -$9.52K | $30.63K | +2,235.7% |
| Free cash flow | -$969.35K | -$198.93K | -$865.19K | -$215.28K | -$157.71K | -387.3% |
| End cash position | $372.10K | $280.63K | $464.85K | $207.64K | $456.76K | +32.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.10
+1.36% from price
SMA 20
0.09
+3.25% from price
SMA 50
0.09
+5.07% from price
SMA 100
0.10
-0.61% from price
SMA 200
0.12
-22.31% from price
EMA 12
0.09
+2.18% from price
EMA 26
0.09
+3.11% from price
EMA 50
0.09
+2.53% from price
RSI (14)
53.1
Neutral
MACD (12,26,9)
0.00
Hist 0.00
ATR (14)
0.00
5.01% of price
Realised vol 30D
83.9%
Annualised
Bollinger upper
0.10
20, 2σ
Bollinger lower
0.09
20, 2σ
50 / 200 cross
Death
0.09 vs 0.12
Trend bias
Below 200
-22.31%
Risk profile
Beta vs SPY
0.21
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
83.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-65.6%
Peak to trough
Max drawdown 5Y
-92.6%
Peak to trough
ATR 14
0.00
5.01% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter
MT Newswires · 4d ago
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
GlobeNewswire · 4d ago
Avicanna Reports Q2 2026 Financial Results
GlobeNewswire · 8d ago
Avicanna Launching Rapid Onset Medical Cannabis Portfolio in Canada
MT Newswires · 37d ago
Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
GlobeNewswire · 38d ago
Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
GlobeNewswire · 53d ago
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
GlobeNewswire · 69d ago
Avicanna Announces Closing of Non-Brokered Private Placement
GlobeNewswire · 71d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.